Thank you to everyone who attended our Industry Theater presentation at the ATS 2023 International Conference where we discussed how OSIC is “Finding Meaningful Digital Biomarkers and AI for Rare Lung Disease.”

Our AI showcase and roundtable discussion featured a panel of five OSIC members who shared their key learnings about using our diverse, global repository of anonymized HRCT scans and clinical data to find novel biomarkers. They also shared insights about how the OSIC data can be used to develop AI-based applications for improving patient care and facilitating precision medicine for those living with rare lung diseases.

OSIC was selected for poster presentation during the weekend’s 2023 Respiratory Innovation Summit (RIS). It was an honor to get in front of more than 350 global leaders in the respiratory industry who are leading the charge to create powerful new treatments for diseases of the lungs and airways.